Cargando…
Severe congenital neutropenia, a genetically heterogeneous disease group with an increased risk of AML/MDS
Over the past decade, enormous progress has been made in the understanding of severe congenital neutropenia (SCN), by identification of several causal gene mutations: in ELANE, GFI1, HAX1, WAS and G3PC3. SCN is a preleukemic condition, independent of the genetic subtype. Acquired CSF3R mutations are...
Autores principales: | Vandenberghe, Peter, Beel, Karolien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206537/ https://www.ncbi.nlm.nih.gov/pubmed/22053285 http://dx.doi.org/10.4081/pr.2011.s2.e9 |
Ejemplares similares
-
Inherited predisposition to MDS/AML
por: Rio Machin, Ana, et al.
Publicado: (2018) -
IRAK1: oncotarget in MDS and AML
por: Beverly, Levi J., et al.
Publicado: (2014) -
The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants
por: Rio-Machin, Ana, et al.
Publicado: (2020) -
Age-related epigenetic drift in the pathogenesis of MDS and AML
por: Maegawa, Shinji, et al.
Publicado: (2014) -
Risk of infection in elderly patients with AML and MDS treated with hypomethylating agents
por: Livio, Pagano, et al.
Publicado: (2018)